Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 3120138, 5 pages
https://doi.org/10.1155/2017/3120138
Research Article

Serological Analysis and Drug Resistance of Chlamydia pneumoniae and Mycoplasma pneumoniae in 4500 Healthy Subjects in Shenzhen, China

1Shenzhen People’s Hospital, Shenzhen, Guangdong, China
2Shenzhen YHLO Biotech Co., Ltd., Shenzhen, Guangdong, China

Correspondence should be addressed to Yan Wu; moc.qq@2715327782 and Yang Jiao; moc.anis@uycor

Received 20 April 2017; Accepted 17 July 2017; Published 19 September 2017

Academic Editor: Kong Chen

Copyright © 2017 Dong Du et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Principi and S. Esposito, “Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections,” Lancet Infectious Diseases, vol. 1, no. 5, pp. 334–344, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. P. L. T. Huong, P. T. Hien, N. T. P. Lan, T. Q. Binh, D. M. Tuan, and D. D. Anh, “First report on prevalence and risk factors of severe atypical pneumonia in Vietnamese children aged 1-15 years,” BMC Public Health, vol. 14, no. 1, article no. 1304, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Zemin, Y. Cai, and L. Beibei, “Analysis of the causes of chronic cough in children of different ages,” Journal of Clinical Pediatrics, vol. 29, no. 2, pp. 138–141, 2011. View at Google Scholar
  4. W. Yanting and S. Wang, “Correlation analysis of chronic cough with Mycoplasma pneumoniae and Chlamydia pneumoniae infection in children,” Health Horizon, vol. 21, no. 10, pp. 41-42, 2013. View at Google Scholar
  5. Z. Qingyi, X. Jing, and L. Jingdong, “Epidemiological analysis ofMycoplasma pneumoniae in children in Qingdao,” Chinese Journal of Nosocomiology, vol. 14, no. 3, pp. 248–250, 2004. View at Google Scholar
  6. Z. Shunying, “Clinical manifestations and extrapulmonary complications of Mycoplasma pneumoniae infection,” Journal of Applied Clinical Pediatrics, vol. 22, no. 4, pp. 249-250, 2007. View at Google Scholar
  7. M. M. Hall, J. T. Finnoff, and J. Smith, Musculoskeletal Complications of Fluoroquinolones: Guidelines And Precautions for Usage in The Athletic Population, vol. 3, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Bebear, S. Pereyre, and O. Peuchant, “Mycoplasma pneumoniae: susceptibility and resistance to antibiotics,” Future Microbiology, vol. 6, no. 4, pp. 423–431, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Demers et al., “Effects of tetracyclines on skeletal growth and dentition. A report by the the nutrition committee of the canadian paediatric society,” Medical Association Journal, vol. 99, no. 17, pp. 849–854, 1968. View at Google Scholar
  10. R. Marre and H. Hahn, “Medizinische mikrobiologie und infektiologie,” Journal Springer Verlag Berlin, vol. 87, no. 2, pp. 427–436, 2005. View at Google Scholar
  11. C. Hermann, K. Gueinzius, A. Oehme, S. Von Aulock, E. Straube, and T. Hartung, “Comparison of quantitative and semiquantitative enzyme-linked immunosorbent assays for immunoglobulin G against Chlamydophila pneumoniae to a microimmunofluorescence test for use with patients with respiratory tract infections,” Journal of Clinical Microbiology, vol. 42, no. 6, pp. 2476–2479, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. D. S. Halvorsen, T. Børvik, I. Njølstad, T. J. Gutteberg, L. H. Vorland, and J.-B. Hansen, “Chlamydia pneumoniae IgA- and IgG antibodies in young survivors of myocardial infarction. A comparison of antibody detection by a microimmunofluorescence test and an enzyme immunoassay,” Journal of Internal Medicine, vol. 251, no. 2, pp. 142–147, 2002. View at Publisher · View at Google Scholar · View at Scopus